Add BrightSurf on Google Email

The anti-acne medicine isotretinoin, which can cause defects in a developing fetus, is now used by almost 2 in 1,000 girls and women of childbearing age, according to analysis of German database of 25 million

A population-based study in Germany reveals almost 2 in 1,000 girls and women of childbearing age are prescribed isotretinoin, a medication linked to fetal defects. The study found a significant increase in isotretinoin-exposed pregnancies, highlighting the need for better monitoring and guidance.

SourcePLOS·JournalPLOS Medicine·DateJan 25, 2024

A special Journal of Intensive Medicine issue explores the depths of intensive care medicine

A special Journal of Intensive Medicine issue explores the latest research findings on ICU infections, prevention strategies, and innovative approaches to sepsis management. The studies shed light on key challenges and advancements in critical care, highlighting the need for personalized treatment methods.

SourceCactus Communications·JournalJournal of Intensive Medicine·TypeSystematic review·DateJan 12, 2024

Benzodiazepine use during pregnancy and risk of miscarriage

A nationwide case-time-control study found an association between benzodiazepine use during pregnancy and an increased risk of miscarriage. The results suggest that healthcare professionals should carefully weigh the benefits and risks of using benzodiazepines to treat psychiatric and sleep disorders in pregnant women.

SourceJAMA Network·JournalJAMA Psychiatry·DateDec 27, 2023

Doxycycline prophylaxis use low and did not prevent STIs among cisgender women

A recent study found that doxycycline prophylaxis did not prevent bacterial sexually transmitted infections (STIs) among cisgender women, despite being prescribed to 18% of participants. The study also revealed high rates of antibiotic-resistant gonorrhea, which may be due to low adherence and limited treatment options.

SourceHennepin Healthcare Research Institute·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateDec 21, 2023

How effective are opioid medications for cancer pain?

A recent review of opioid medicines for cancer pain found surprisingly large gaps in evidence regarding their true benefits. Non-steroidal anti-inflammatory drugs (NSAIDs) may be at least as effective as some opioids for background cancer pain, offering potential alternatives to reduce dependence and waning analgesia over time.

SourceUniversity of Sydney·JournalCA A Cancer Journal for Clinicians·TypeSystematic review·DateDec 18, 2023

Where patients live impacts whether they pick up their heart-failure medications

A new study by NYU Langone Health found that patients from lower socioeconomic areas were less likely to fill their heart-failure medications, highlighting the importance of neighborhood-level interventions to improve access to lifesaving drugs. The research team plans to explore additional barriers, such as cost and language barriers,...

Researchers profile pollutants present in an important river basin in São Paulo state, Brazil

A study by UNICAMP researchers found high concentrations of contaminants in the Piracicaba, Capivari and Jundiaí River Basin, including PFAS compounds, pesticides, and industrial chemicals. The study highlights the severity of pollution in the region, which supplies water for drinking, irrigation, and industry.

Human insulin less temperature-sensitive than previously thought

A new Cochrane review has found that human insulin can be stored at room temperature for up to six months without losing potency. This breakthrough research offers hope to millions of people living with diabetes in low- and middle-income countries, particularly those with limited access to refrigeration or healthcare.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateNov 2, 2023

Esketamine nasal spray: an option for patients with treatment-resistant depression

A new study reveals that esketamine nasal spray is effective in treating treatment-resistant depression, with 27.1% of patients achieving remission after 8 weeks compared to 17.6% on quetiapine XR. Long-term data shows sustained remission rates at 21.7% for esketamine NS and 14.1% for quetiapine XR.

SourceChampalimaud Centre for the Unknown·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 4, 2023

CARB-X is funding a University of Melbourne research team to develop an oral therapeutic to treat drug-resistant community-acquired bacterial pneumonia

A University of Melbourne research team is developing an oral therapeutic to restore the activity of common antibiotics used to treat community-acquired bacterial pneumonia. The project aims to combat antibiotic-resistant bacteria and reduce healthcare costs, with potential applications in low- and middle-income countries.

Management of acetaminophen poisoning in the US and Canada

The study provides a comprehensive framework for diagnosing and treating acetaminophen poisoning, emphasizing the importance of early detection and aggressive management. Key findings include the need for prompt assessment and treatment with activated charcoal and N-acetylcysteine, as well as the role of monitoring liver function tests.

SourceJAMA Network·JournalJAMA Network Open·DateAug 8, 2023

Gene therapy treats chronic pain by dialing down sodium

Researchers at NYU College of Dentistry developed a gene therapy that regulates sodium ion channel activity to alleviate chronic pain. By targeting the specific region where CRMP2 binds to NaV1.7, they were able to reduce sodium influx and quiet down neurons, providing relief from pain in cell and animal studies.

SourceNew York University·JournalProceedings of the National Academy of Sciences·DateJul 27, 2023

Breakthrough in solid-state storage innovates how biological materials are stored and handled

Researchers at California Polytechnic State University have developed a novel method for storing biological materials such as RNA and proteins in a solid-state, resembling a pill or tablet that dissolves in water for on-demand use. This innovation overcomes current limitations in storage and handling, making it easier to access these m...

SourceCalifornia Polytechnic State University·JournalACS Synthetic Biology·TypeExperimental study·DateJul 26, 2023

Treating childhood ADHD with stimulant meds not associated with increased substance use later in life, study finds

Researchers at the University of Pittsburgh School of Medicine found no evidence that prescription stimulant treatment in childhood increases the risk of substance use disorder (SUD) later in life. The study, published in JAMA Psychiatry, suggests that stimulants are an effective treatment for ADHD with few side effects.

SourceUniversity of Pittsburgh·JournalJAMA Psychiatry·DateJul 5, 2023

Polymyalgia Rheumatica could be safely, effectively treated with tofacitinib, avoiding the need for steroids, per new proof-of-concept Randomized Controlled Trial

A new proof-of-concept Randomized Controlled Trial found tofacitinib effective and safe for Polymyalgia Rheumatica treatment, potentially avoiding steroid use. The study's results suggest a promising alternative treatment option for patients with this condition.

SourcePLOS·JournalPLOS Medicine·TypeRandomized controlled/clinical trial·DateJun 29, 2023

When at first you don’t succeed: Tobacco researchers to test whether switching medications helps people to quit smoking after an unsuccessful first attempt

A randomized trial will be conducted to test whether sticking with the initial medication or switching to a different one increases quitting success. The study aims to provide guidance for clinicians on handling relapses and may explore the effectiveness of e-cigarettes as an alternative to traditional cigarettes.

New Journal of Pharmaceutical Analysis articles showcase innovative approaches for diagnostics and drug screening and evaluation

Recent studies in the New Journal of Pharmaceutical Analysis feature novel diagnostic tools, RNA sequencing-based workflows, and mechanical property evaluations to enhance cancer and cardiovascular disease treatment outcomes. These innovations aim to improve the therapeutic effect of drugs and promote personalized medicine.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateJun 21, 2023

Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn

A Cochrane review found that most antidepressants used to manage chronic pain lack sufficient evidence of their effectiveness, with only duloxetine showing reliable pain relief. The review also revealed that harms from many commonly recommended drugs have not been well studied, posing a global public health concern.

SourceUniversity of Southampton·JournalCochrane Database of Systematic Reviews·TypeMeta-analysis·DateMay 9, 2023

Inhaled ethanol may treat respiratory infections and stop pandemics

A new study found that inhaling low concentrations of ethanol vapor can inactivate the influenza A virus in mice without harmful side effects. The researchers believe this method could also treat similar viruses like Covid-19 and potentially stop pandemics. However, further evaluation is needed to ensure its efficacy and safety on humans.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalThe Journal of Infectious Diseases·TypeExperimental study·DateApr 26, 2023

Study: Treatment for opioid addiction lags despite policies designed to increase it

A new study finds that buprenorphine initiation rates and six-month retention rates remain flat despite policy changes aimed at increasing access to the medication. Only 22% of patients who started treatment kept refilling their prescriptions for at least six months, highlighting barriers to prescribing enough of the life-saving drug.

SourceMichigan Medicine - University of Michigan·JournalJAMA·TypeData/statistical analysis·DateApr 25, 2023

New study shows medication adherence tool is world’s first to predict hospital admissions and readmissions of Type 2 Diabetes patients

A new study reveals that the SPUR tool, developed by Kingston University and Observia, can accurately predict hospital admissions and early readmissions in people with Type 2 Diabetes. The tool has been found to be effective in reducing hospital admissions and improving patient outcomes.

SourceKingston University·JournalPatient Preference and Adherence·TypeObservational study·DateMar 20, 2023

Poor healthcare experiences lead caregivers to self-medicate, study shows

A recent study published in Research in Social and Administrative Pharmacy found that about one-third of caregivers self-medicate. Carriers who reported unfavorable healthcare experiences were more likely to take personal care into their own hands. The research team recommends that healthcare professionals should interact with caregive...

SourceUniversity of Tsukuba·JournalResearch in Social and Administrative Pharmacy·DateJan 24, 2023

Pharmacists can start patients on road to recovery from opioid use disorder, study shows

A study shows that pharmacies can offer a safe starting point for patients with opioid use disorder, leading to higher rates of retention in treatment. The pharmacy-based model increases access to buprenorphine, a lifesaving medication, for diverse patient populations and promotes racial and economic equity.

SourceBrown University·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJan 11, 2023

How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

A study from Japan found that variations in psychiatric diagnoses across different cultures can affect the efficacy of antipsychotics in clinical trials. Researchers analyzed data from 28 double-blind randomized trials and found that psychotic features were associated with varying therapeutic responses to antipsychotic medications.

SourceFujita Health University·JournalPsychiatry and Clinical Neurosciences·TypeMeta-analysis·DateJan 10, 2023

Use of cannabis, other pain treatments among adults with chronic pain in states with medical cannabis programs

A survey study found that 3 in 10 adults with chronic pain in states with medical cannabis laws used cannabis to manage their pain, often substituting it for other pain medications. The study highlights the importance of researching the effectiveness and potential adverse consequences of cannabis for chronic pain management.

SourceJAMA Network·JournalJAMA Network Open·DateJan 6, 2023